Does Mounjaro (Tirzepatide) Cause Tinnitus? What the Evidence Shows

There is no proof that Mounjaro (tirzepatide) causes tinnitus. Some pharmacovigilance data show a small tinnitus and ear-symptom signal across GLP-1-based drugs, and tirzepatide is included in that class. But the evidence for tirzepatide is newer and weaker than for semaglutide, and a reported association is not the same as cause.

What does the current evidence actually say?

Researchers study drug side effects partly through pharmacovigilance databases, where clinicians and patients report symptoms that appear during treatment. A 2025 analysis in the Laryngoscope examined ear, nose and throat adverse events reported with GLP-1 receptor agonists, a class that includes tirzepatide. It found reports of tinnitus and other otologic symptoms (summary on PubMed).

That is a signal worth noting. It is not confirmation. Disproportionality signals can be shaped by how many people take a drug, how much media attention it gets, and who reports symptoms. They cannot prove that the drug caused the symptom in any individual.

For tirzepatide specifically, the picture is even less settled. Tirzepatide is a dual GIP/GLP-1 agonist and reached wide use more recently than semaglutide. That means fewer years of reports and smaller numbers behind any tirzepatide-only estimate. Read the tirzepatide data as emerging and provisional.

For the fuller class-wide discussion, see our pillar guide, Does Ozempic or Wegovy Cause Tinnitus or Hearing Problems? What the Evidence Actually Shows (2026).

Why is it so hard to link Mounjaro to tinnitus?

Tinnitus is common. It can follow noise exposure, ageing, ear wax, ear infection, high blood pressure, stress, and many medicines used for unrelated conditions (MedlinePlus: Tinnitus).

People starting Mounjaro often have type 2 diabetes, obesity, or cardiovascular risk factors. Several of these conditions are themselves linked to hearing and ear symptoms. So when tinnitus appears during treatment, it is genuinely unclear whether the drug, the underlying condition, or an unrelated cause is responsible. This overlap is exactly why a reported association cannot be treated as proof of cause.

Is Mounjaro known to be ototoxic?

Ototoxic drugs are medicines with an established ability to damage the inner ear or hearing nerve. The well-documented ones include certain chemotherapy agents, some strong antibiotics, loop diuretics, and high-dose aspirin (ASHA: Ototoxic Medications).

Tirzepatide is not on that established list. The current tinnitus discussion around GLP-1 medicines is a developing safety question, not a confirmed ototoxic effect. Keep that distinction clear when you read alarming headlines.

What should I do if I get tinnitus on Mounjaro?

• Do not stop or change your dose on your own. Stopping a diabetes or weight medication abruptly can carry its own risks. Raise it with the prescriber who started it.
• Book a hearing assessment so the tinnitus can be characterised and any treatable cause (like ear wax or infection) can be ruled out. You can arrange a hearing test or reach us here.
• Note the pattern. When it started, whether it is in one ear or both, and whether your hearing has changed. This helps both your doctor and your audiologist.
• Protect your ears from loud noise, manage blood pressure, and reduce caffeine if it seems to worsen the ringing.

If leaving home is difficult, we also offer a home visit.

When is tinnitus or hearing change an emergency?

Sudden hearing loss, or sudden severe tinnitus in one ear, especially with dizziness, is a medical emergency. Sudden sensorineural hearing loss can sometimes be treated if care starts quickly, so it should not be delayed (MedlinePlus: Hearing loss). Seek same-day medical attention rather than waiting for a routine appointment.